These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 29286094)
1. Sphingosine-1-phosphate ameliorates the cardiac hypertrophic response through inhibiting the activity of histone deacetylase-2. Yan H; Yi S; Zhuang H; Wu L; Wang DW; Jiang J Int J Mol Med; 2018 Mar; 41(3):1704-1714. PubMed ID: 29286094 [TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-Phosphate Protects Against the Development of Cardiac Remodeling via Sphingosine Kinase 2 and the S1PR2/ERK Pathway. Yan H; Zhao H; Yi SW; Zhuang H; Wang DW; Jiang JG; Shen GF Curr Med Sci; 2022 Aug; 42(4):702-710. PubMed ID: 35963947 [TBL] [Abstract][Full Text] [Related]
4. Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart. Eom GH; Cho YK; Ko JH; Shin S; Choe N; Kim Y; Joung H; Kim HS; Nam KI; Kee HJ; Kook H Circulation; 2011 May; 123(21):2392-403. PubMed ID: 21576649 [TBL] [Abstract][Full Text] [Related]
6. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes. Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940 [TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-phosphate receptor 2 mediates endothelial cells dysfunction by PI3K-Akt pathway under high glucose condition. Liu W; Liu B; Liu S; Zhang J; Lin S Eur J Pharmacol; 2016 Apr; 776():19-25. PubMed ID: 26921757 [TBL] [Abstract][Full Text] [Related]
8. Palmatine attenuates isoproterenol-induced pathological hypertrophy via selectively inhibiting HDAC2 in rats. Yuan Y; Peng W; Liu Y; Xu Z Int J Immunopathol Pharmacol; 2017 Dec; 30(4):406-412. PubMed ID: 29164959 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression. Morales CR; Li DL; Pedrozo Z; May HI; Jiang N; Kyrychenko V; Cho GW; Kim SY; Wang ZV; Rotter D; Rothermel BA; Schneider JW; Lavandero S; Gillette TG; Hill JA Sci Signal; 2016 Apr; 9(422):ra34. PubMed ID: 27048565 [TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis Can Promote Mouse and Human Primary Mast Cell Angiogenic Potential through Upregulation of Vascular Endothelial Growth Factor-A and Matrix Metalloproteinase-2. Chumanevich A; Wedman P; Oskeritzian CA Mediators Inflamm; 2016; 2016():1503206. PubMed ID: 26884643 [TBL] [Abstract][Full Text] [Related]
11. Antihypertrophic Memory After Regression of Exercise-Induced Physiological Myocardial Hypertrophy Is Mediated by the Long Noncoding RNA Mhrt779. Lin H; Zhu Y; Zheng C; Hu D; Ma S; Chen L; Wang Q; Chen Z; Xie J; Yan Y; Huang X; Liao W; Kitakaze M; Bin J; Liao Y Circulation; 2021 Jun; 143(23):2277-2292. PubMed ID: 33757294 [TBL] [Abstract][Full Text] [Related]
15. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy. Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703 [TBL] [Abstract][Full Text] [Related]
16. EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes. Robert P; Tsui P; Laville MP; Livi GP; Sarau HM; Bril A; Berrebi-Bertrand I J Mol Cell Cardiol; 2001 Sep; 33(9):1589-606. PubMed ID: 11549339 [TBL] [Abstract][Full Text] [Related]
17. Sphingosine 1-phosphate promotes mesenchymal stem cell-mediated cardioprotection against myocardial infarction via ERK1/2-MMP-9 and Akt signaling axis. Chen R; Cai X; Liu J; Bai B; Li X Life Sci; 2018 Dec; 215():31-42. PubMed ID: 30367841 [TBL] [Abstract][Full Text] [Related]
19. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Kong Y; Tannous P; Lu G; Berenji K; Rothermel BA; Olson EN; Hill JA Circulation; 2006 Jun; 113(22):2579-88. PubMed ID: 16735673 [TBL] [Abstract][Full Text] [Related]